SNDX RSI Chart
Last 7 days
-4%
Last 30 days
0.5%
Last 90 days
7.8%
Trailing 12 Months
5.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 | 0 |
2021 | 1.5M | 1.5M | 13.5M | 139.7M |
2020 | 1.5M | 1.5M | 1.5M | 1.5M |
2019 | 1.5M | 1.5M | 1.5M | 1.5M |
2018 | 2.2M | 2.3M | 2.3M | 1.5M |
2017 | 1.2M | 1.2M | 1.2M | 2.1M |
2016 | 775.3K | 923.5K | 1.1M | 1.2M |
2015 | 0 | 0 | 0 | 627.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 07, 2024 | meury william | acquired | - | - | 17,000 | - |
Feb 07, 2024 | goldan keith a. | acquired | - | - | 46,700 | chief financial officer |
Feb 07, 2024 | morrison briggs | acquired | - | - | 17,000 | - |
Feb 07, 2024 | huber martin h. jr. | acquired | - | - | 17,000 | - |
Feb 07, 2024 | jarrett jennifer | acquired | - | - | 17,000 | - |
Feb 07, 2024 | podlesak dennis | acquired | - | - | 34,000 | - |
Feb 07, 2024 | metzger michael a | acquired | - | - | 146,250 | chief executive officer |
Feb 07, 2024 | legault pierre | acquired | - | - | 17,000 | - |
Feb 07, 2024 | katkin keith | acquired | - | - | 17,000 | - |
Feb 07, 2024 | gallagher neil | acquired | - | - | 47,813 | president, head of r&d |
Which funds bought or sold SNDX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | added | 511 | 18,811 | 21,135 | -% |
Mar 21, 2024 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | new | - | 16,855,800 | 16,855,800 | 0.06% |
Mar 18, 2024 | KINGDON CAPITAL MANAGEMENT, L.L.C. | new | - | 32,254,800 | 32,254,800 | 2.02% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 19.85 | 41,163,800 | 93,687,000 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 97.35 | 35,658,300 | 54,066,000 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | added | 1.03 | 240,474 | 717,906 | -% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | sold off | -100 | -544,000 | - | -% |
Feb 26, 2024 | Virtu Financial LLC | new | - | 258,000 | 258,000 | 0.02% |
Feb 20, 2024 | Quarry LP | new | - | 16,208 | 16,208 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | new | - | 533,000 | 533,000 | 0.04% |
Unveiling Syndax Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Syndax Pharmaceuticals Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Syndax Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Revenue | - | - | - | - | - | - | 126,576 | 12,375 | 379 | 379 | 380 | 379 | 379 | 379 | 380 | 379 | 379 | 379 | 380 | 379 | 379 | 379 |
Operating Expenses | 38.2% | 77,906 | 56,355 | 49,678 | 46,015 | 42,034 | 30,827 | 32,407 | 22,713 | 27,542 | 20,240 | 20,232 | 16,989 | 15,479 | 14,585 | 13,528 | 15,753 | 15,190 | 19,713 | 18,220 | 19,330 | 20,130 |
S&GA Expenses | 31.9% | 22,779 | 17,268 | 14,914 | 11,961 | 10,192 | 6,927 | 6,801 | 5,842 | 5,672 | 4,718 | 5,824 | 6,046 | 5,917 | 5,083 | 3,605 | 3,463 | 3,911 | 3,892 | 4,125 | 4,479 | 4,791 |
R&D Expenses | 41.0% | 55,127 | 39,087 | 34,764 | 34,054 | 31,842 | 23,901 | 25,606 | 16,871 | 21,870 | 15,522 | 14,408 | 10,943 | 9,562 | 9,502 | 9,923 | 12,290 | 11,279 | 15,821 | 14,095 | 14,851 | 15,339 |
Interest Expenses | -10.0% | 63.00 | 70.00 | 35.00 | 40.00 | 43.00 | -7.00 | 649 | 634 | 623 | 635 | 635 | 638 | 449 | - | - | - | - | - | - | - | - |
Net Income | -41.7% | -72,473 | -51,146 | -44,615 | -41,126 | -39,194 | 96,198 | -20,639 | -22,910 | -27,723 | -20,423 | -20,437 | -17,062 | -15,236 | -14,000 | -12,829 | -14,916 | -14,302 | -18,837 | -17,338 | -18,388 | -19,398 |
Net Income Margin | 0% | -1.26* | -1.26* | -1.15* | -1.10* | -1.07* | 0.18* | -6.79* | -60.31* | -56.46* | -48.23* | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 0% | -44,667 | -44,667 | -35,385 | -39,242 | -22,908 | 100,695 | -24,958 | -24,059 | -22,603 | -15,645 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 53.5% | 613 | 399 | 431 | 460 | 497 | 360 | 406 | 422 | 450 | 240 | 263 | 280 | 301 | 179 | 193 | 105 | 64.00 | 76.00 | 87.00 | 99.00 | 84.00 |
Current Assets | 52.5% | 581 | 381 | 409 | 442 | 490 | 358 | 392 | 420 | 448 | 238 | 263 | 279 | 299 | 177 | 192 | 104 | 62.00 | 75.00 | 86.00 | 98.00 | 83.00 |
Cash Equivalents | 212.4% | 295 | 95.00 | 97.00 | 58.00 | 74.00 | 71.00 | 120 | 189 | 222 | 71.00 | 68.00 | 64.00 | 115 | 56.00 | 54.00 | 45.00 | 25.00 | 31.00 | 27.00 | 58.00 | 34.00 |
Net PPE | -20.0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | 46.6% | 59.00 | 40.00 | 31.00 | 24.00 | 30.00 | 22.00 | 44.00 | 48.00 | 41.00 | 40.00 | 48.00 | 51.00 | 48.00 | 47.00 | 45.00 | 52.00 | 32.00 | 32.00 | 32.00 | 31.00 | 31.00 |
Current Liabilities | 48.3% | 58.00 | 39.00 | 30.00 | 24.00 | 29.00 | 21.00 | 31.00 | 31.00 | 21.00 | 29.00 | 24.00 | 25.00 | 19.00 | 15.00 | 12.00 | 19.00 | 18.00 | 18.00 | 17.00 | 16.00 | 16.00 |
Shareholder's Equity | 54.3% | 554 | 359 | 400 | 436 | 467 | 338 | 362 | 375 | 408 | 199 | 215 | 228 | 252 | 132 | 148 | 54.00 | 32.00 | 44.00 | 55.00 | 69.00 | 53.00 |
Retained Earnings | -8.7% | -902 | -829 | -778 | -734 | -693 | -653 | -618 | -580 | -543 | -639 | -619 | -596 | -568 | -548 | -527 | -510 | -495 | -481 | -468 | -453 | -439 |
Additional Paid-In Capital | 22.4% | 1,456 | 1,190 | 1,179 | 1,170 | 1,161 | 994 | 982 | 956 | 952 | 839 | 834 | 825 | 821 | 680 | 675 | 564 | 527 | 525 | 524 | 522 | 492 |
Shares Outstanding | 21.8% | 85.00 | 70.00 | 69.00 | 68.00 | 68.00 | 60.00 | 60.00 | 59.00 | 52.00 | 52.00 | 52.00 | 51.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 1,452,442 | - | - | - | 1,084 | - | - | - | 833 | - | - | - | 500 | - | - | - | 208 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 7.4% | -41,349 | -44,653 | -35,371 | -39,228 | -22,894 | -28,544 | -40,306 | -41,931 | 100,709 | -24,944 | -24,045 | -22,589 | -15,631 | -18,297 | -21,407 | -15,925 | -12,727 | -8,529 | -12,525 | -16,831 | -15,043 |
Share Based Compensation | 0.1% | 8,327 | 8,321 | 8,065 | 6,238 | 4,241 | 4,362 | 3,938 | 3,478 | 3,929 | 3,381 | 3,240 | 2,767 | 2,035 | 3,063 | 2,130 | 1,829 | 1,525 | 1,550 | 1,338 | 1,592 | 1,472 |
Cashflow From Investing | -140.6% | -16,290 | 40,077 | 73,907 | 19,915 | -137,629 | -6,793 | -49,948 | 8,182 | -59,956 | 26,631 | 21,680 | -29,228 | -64,140 | 19,275 | -78,612 | -19,053 | 6,596 | 12,364 | -18,931 | 12,752 | 15,962 |
Cashflow From Financing | 13864.5% | 258,483 | 1,851 | 1,324 | 2,474 | 163,502 | -13,525 | 21,720 | 557 | 109,779 | 1,705 | 6,020 | 960 | 138,658 | 1,767 | 109,001 | 54,998 | 58.00 | 80.00 | 6.00 | 28,426 | 6,145 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues: | |||
License fees | $ 0 | $ 0 | $ 139,709 |
Total revenues | $ 0 | $ 0 | $ 139,709 |
Type of revenue [extensible list] | us-gaap:LicenseMember | us-gaap:LicenseMember | us-gaap:LicenseMember |
Operating expenses: | |||
Research and development | $ 163,032 | $ 118,499 | $ 88,248 |
Selling, general and administrative | 66,922 | 33,258 | 25,241 |
Total operating expenses | 229,954 | 151,757 | 113,489 |
(Loss) income from operations | (229,954) | (151,757) | 26,220 |
Other income (expense): | |||
Interest expense | (208) | (3,137) | (1,899) |
Interest income | 21,163 | 5,872 | 403 |
Other (expense) income, net | (361) | (316) | 202 |
Total other income (expense) | 20,594 | 2,419 | (1,294) |
Net (loss) income | (209,360) | (149,338) | 24,926 |
Net (loss) income attributable to common stockholders | $ (209,360) | $ (149,338) | $ 24,926 |
Net (loss) income Per Share: | |||
Basic (loss) earnings per share attributable to common stockholders | $ (2.98) | $ (2.46) | $ 0.48 |
Diluted (loss) earnings per share attributable to common stockholders | $ (2.98) | $ (2.46) | $ 0.46 |
Weighted-average common shares used in calculating: | |||
Basic (loss) earnings per share attributable to common stockholders | 70,370,519 | 60,760,906 | 52,064,809 |
Diluted (loss) earnings per share attributable to common stockholders | 70,370,519 | 60,760,906 | 53,622,904 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 295,394 | $ 74,356 |
Short-term investments | 275,304 | 401,446 |
Short-term deposits | 6,885 | 8,595 |
Collaboration receivable, net | 0 | 3,474 |
Prepaid expenses and other current assets | 3,293 | 1,915 |
Total current assets | 580,876 | 489,786 |
Long-Term Investments | 29,829 | 5,469 |
Property and equipment, net | 8 | 20 |
Right-of-use asset | 1,487 | 1,039 |
Restricted cash | 217 | 115 |
Other assets | 463 | 807 |
Total assets | 612,880 | 497,236 |
Current liabilities: | ||
Accounts payable | 9,961 | 4,350 |
Collaboration payable, net | 7,232 | 0 |
Accrued expenses and other current liabilities | 39,856 | 24,276 |
Current portion of right-of-use liability | 1,035 | 434 |
Current Portion Of Capital Lease | 12 | 5 |
Total current liabilities | 58,096 | 29,065 |
Long-term liabilities: | ||
Right-of-use liability, less current portion | 578 | 709 |
Capital Lease Less Current Portion | 10 | 13 |
Total long-term liabilities | 588 | 722 |
Total liabilities | 58,684 | 29,787 |
Commitments and contingencies (Note 16) | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized; 0 shares outstanding at December 31, 2023 and December 31, 2022 | 0 | 0 |
Common stock, $0.0001 par value, 200,000,000 and 100,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively; 84,826,632 and 68,111,385 shares outstanding at December 31, 2023 and December 31, 2022, respectively | 8 | 7 |
Additional paid-in capital | 1,456,370 | 1,161,288 |
Accumulated other comprehensive income (loss) | 218 | (806) |
Accumulated deficit | (902,400) | (693,040) |
Total stockholders' equity | 554,196 | 467,449 |
Total liabilities and stockholders' equity | $ 612,880 | $ 497,236 |